Free Trial

Intra-Cellular Therapies (ITCI) SEC Filings & 10K Form

$67.77
-0.64 (-0.94%)
(As of 06/14/2024 06:55 PM ET)

Recent Intra-Cellular Therapies SEC Filings

DateFilerForm TypeView
05/07/2024
6:40 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:43 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
3:46 PM
Intra-Cellular Therapies (Filer)
Form DEFA14A
04/29/2024
3:48 PM
Intra-Cellular Therapies (Filer)
Form ARS
04/24/2024
3:20 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
4:23 PM
Intra-Cellular Therapies (Filer)
Form 424B5
04/18/2024
4:25 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:40 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:37 PM
Intra-Cellular Therapies (Filer)
Form 424B5
04/16/2024
6:10 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:15 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:44 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:31 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:32 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:52 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:38 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
4:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:44 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:36 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:27 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:04 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:41 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:57 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Jeff Bezos & 48 Members of Congress Are Buying ONE Sector… (Ad)

Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…

Click here for the details
02/27/2024
7:00 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:22 PM
Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:33 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:22 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:42 AM
Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
11:40 AM
Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/05/2024
5:02 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:07 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:10 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:13 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:47 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:39 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:41 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
6:47 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:08 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
5:02 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
6:54 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:43 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:46 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:38 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
10:15 AM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:52 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
4:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
3:15 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
12:06 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
7:01 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:01 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
4:29 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
4:30 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
7:40 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
3:13 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:13 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:18 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
3:40 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:09 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
6:44 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2023
4:47 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
3:13 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
5:07 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:07 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:08 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4/A
07/05/2023
3:30 PM
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Scary Fed Idea To Turn Your Dollars Into a Digital Power Grab (Ad)

Cash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with their own controllable, traceable, programmable digital currency.

Act now and claim your free information kit before it's too late!
07/05/2023
3:30 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM
Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ITCI) was last updated on 6/17/2024 by MarketBeat.com Staff

From Our Partners